Dose: 50 mg
Single Dose: 50 (50)
Frequency: 6 hourly
Route: PO
Instructions:

. It is of Synthetic origin. . The Molecular Weight of Riluzole is 234.20.

Riluzole is contraindicated in conditions like Neutropenia,Pregnancy,Lactation,Increase liver transaminase.

Riluzole produces potentially life-threatening effects which include Neutropenia. which are responsible for the discontinuation of Riluzole therapy.The symptomatic adverse reactions produced by Riluzole are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Anorexia, Tachycardia, Pain, Asthenia, Abdominal distress, Hypertonia.

Riluzole is primarily indicated in conditions like Motor neuron disease.

No data regarding the interactions of Riluzole was found.

Abnormal LFTs Increased Alkaline Phosphatase Levels+ve Coomb`s tests

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store at room temperature. Protect from Sunlight.

Liver fuction tests should be carried out before and throughout the tratment. White blood cell counts should be determined in fibrile illness and riluzole discontinued if neutripenia occurs. Extreme caution should be excercized in patients with renal impairment or those with a previous history of liver disorders. It should be used with caution while engaging in activities requiring alertness.